Literature DB >> 29401132

Defining Infection in Breast Reconstruction: A Literature Review.

Vitali Azouz1, Shayda Mirhaidari, Douglas S Wagner.   

Abstract

PURPOSE: Postoperative infection is the most common complications after implant-based immediate breast reconstruction (IBR), with reported rates ranging from less than 1% to 43%. This heterogeneity among the literature may be explained by a lack of consensus on the definition of postoperative infection. The purpose of this study was to review the prevalence of infection and how it is defined in studies involving prosthetic-based IBR. It is necessary to establish a clear definition of infection to standardize the reporting of complications.
METHODS: A comprehensive literature review was performed to identify infection rates among implant/tissue expander-based IBR performed between 1996 and 2017. A PubMed search using the keywords "immediate breast reconstruction" matched with "infection" and "tissue expanders" or "implant" was performed. Reconstructive modality, infection rates, and definitions were recorded and reviewed.
RESULTS: An initial search provided 196 articles; 138 articles met inclusion criteria and were reviewed. Eighty-five (61%) articles failed to define infection and reported an infection rate ranging from 0% to 22%. The studies that characterized infection had highly variable definitions. Whereas some authors chose to define infection based on Centers for Disease Control guidelines, others used more subjective findings such as clinical signs of infection.
CONCLUSIONS: Currently, there is no consensus on the definition of infection after implant-based IBR. We propose that the definition should include the administration of antibiotics beyond the surgeon's standard perioperative period with or without the presence of localized clinical signs of infection (erythema, pain, increased temperature, etc). A universal definition of postoperative infection after implant-based IBR that accurately captures the incidence of infection will allow better comparisons between future studies.

Entities:  

Mesh:

Year:  2018        PMID: 29401132     DOI: 10.1097/SAP.0000000000001336

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  5 in total

1.  Tissue Expander-Based Breast Reconstruction at a Major Safety-Net Hospital: Managing the Outsized Risk of Infection.

Authors:  Lindsey N Urquia; Silas P Henderson; Jordyn T Farewell; Sofia Duque; Maycie Garibay; Julia Nevin; Andrew Y Zhang
Journal:  Aesthet Surg J Open Forum       Date:  2022-05-02

2.  Protocol for Prevention and Monitoring of Surgical Site Infections in Implant-Based Breast Reconstruction: Preliminary Results.

Authors:  Giovanni Papa; Andrea Frasca; Nadia Renzi; Chiara Stocco; Giuseppe Pizzolato; Vittorio Ramella; Zoran Marij Arnež
Journal:  Medicina (Kaunas)       Date:  2021-02-08       Impact factor: 2.430

3.  Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction: A Randomized Clinical Trial.

Authors:  Jessica Gahm; Anna Ljung Konstantinidou; Jakob Lagergren; Kerstin Sandelin; Martin Glimåker; Hemming Johansson; Marie Wickman; Jana de Boniface; Jan Frisell
Journal:  JAMA Netw Open       Date:  2022-09-01

4.  Implant-based Breast Reconstruction Outcomes Comparing Freeze-dried Aseptic Alloderm and Sterile Ready-to-use Alloderm.

Authors:  Anna S Widmyer; Shayda J Mirhaidari; Douglas S Wagner
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-12-31

5.  Improved Diagnostic Accuracy of Periprosthetic Breast Infection: Novel Application of the Alpha Defensin-1 Biomarker.

Authors:  Marten N Basta; Paul Y Liu; Daniel Kwan; Karl H Breuing; Rachel Sullivan; Charles C Jehle; Jonathan L Bass; Richard J Zienowicz; Scott Schmidt
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.